Episode Details

Back to Episodes
Workers Comp Unwrapped Episode 503: MTUS Drug List v.14 Is Live: What Changed, What's Out, and How to Bill It Correctly in WC

Workers Comp Unwrapped Episode 503: MTUS Drug List v.14 Is Live: What Changed, What's Out, and How to Bill It Correctly in WC

Season 5 Episode 3 Published 4 weeks ago
Description

Send us Fan Mail

Two episodes ago it was the UR and IMR overhaul. Last episode it was the 10-day IMR clock for formulary drug disputes. In this episode, Aneeq and Angela turn to the drug list itself: MTUS Drug List v.14, effective April 30, 2026. It's built off updates to the ACOEM Traumatic Brain Injury Guideline, which means the practical exposure lands hardest on pain management and neurology providers treating head injury and concussion claims. Angela walks through what moved onto "special fill," what got added as fully exempt, what's brand new to the list entirely, and why none of that matters if the billing and documentation behind it doesn't hold up.

Drawing from her 15 years of industry experience, Angela breaks down the difference between exempt, non-exempt, and special-fill status, what changed for migraine medications specifically, the two drugs new to the list outright, and the off-formulary documentation that has to accompany any drug that isn't following the rules on paper.

The conversation explores:

  • Why a TBI guideline update is really a migraine and headache medication update
  • The difference between "exempt" and "special fill" and why providers keep confusing them
  • Which drugs just moved to special-fill status, and what that actually changes at the pharmacy counter
  • The two drugs newly added as exempt outright
  • What's brand new to the list and why one of those additions matters for TBI-adjacent claims specifically
  • How to document an off-formulary request so it survives a UR look
  • The billing-side mistakes that turn a compliant prescription into a denied claim
  • A tactical checklist for getting ahead of v.14 before it catches a claim

Key takeaway: v.14 isn't a long list of unrelated drug changes. It's a coherent update to how headache and migraine medication is supposed to move through the system, and the providers who get hurt are the ones treating status changes as a footnote instead of updating their point-of-sale and billing processes to match.

Support the show

#podcast #newepisode #episode #healthcare #hospitals #medical #workerscomp #attorney #doctors #california #usa #billing #workerscompbilling #trump #medicalprovider #LienFiling #SBR #Revenuecycle #DOR #Eamscasesearh #DIR #Credentialing #Collections #Insurancepayments #LienFunding #WCclaims


For more info
Call 📱 888-296-1109
Book Appointment Now |
https://medicallienmgt.com/contact/

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us